Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas-Reference-Cited by-同舟云学术

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Published:2021-11-26 Issue:1 Volume:39 Page:14-24
ISSN:1433-7398
Container-title:Brain Tumor Pathology
language:en
Short-container-title:Brain Tumor Pathol

Author:

Nishikawa Tomohide,Watanabe Reiko,Kitano Yotaro,Yamamichi Akane,Motomura Kazuya,Ohka Fumiharu,Aoki Kosuke,Hirano Masaki,Kato Akira,Yamaguchi Junya,Maeda Sachi,Kibe Yuji,Saito Ryuta,Wakabayashi Toshihiko,Kato Yukinari,Sato Shuta,Ogino Tomoyoshi,Natsume Atsushi,Ito Ichiro

Funder

Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10014-021-00418-x.pdf

Reference30 articles.

1. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

2. Louis DN, Wesseling P, Paulus W et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol 135:481–484